Etonogestrel implant at the time of mifepristone for medical abortion

Autor: Sonalkar, S., Hou, M., Finneseth, M., Petricone, R., Arlos, A., Kattan, D., Borgatta, L.

Publikováno v: In Contraception September 2012 86(3):298-298

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Mifepristone and misoprostol compared to osmotic dilators for cervical preparation prior to surgical abortion at 15-18 weeks' gestation: a randomised controlled non-inferiority trial.

Autor: Paris AE; Obstetrics and Gynecology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA amy.e.paris@hitchcock.org.; Dartmouth College Geisel School of Medicine, Hanover, New Hampshire, USA., Vragovic O; Boston Medical Center, Boston, Massachusetts, USA., Sonalkar S; Obstetrics and Gynecology, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Finneseth M; Obstetrics and Gynecology, Boston University School of Medicine, Boston, Massachusetts, USA., Borgatta L; Obstetrics and Gynecology, Boston University School of Medicine, Boston, Massachusetts, USA.

Publikováno v: BMJ sexual & reproductive health [BMJ Sex Reprod Health] 2019 Nov 21. Date of Electronic Publication: 2019 Nov 21.